Windlas Biotech Limited (BOM:543329)

Market Cap	19.30B
Revenue (ttm)	7.60B
Net Income (ttm)	609.94M
Shares Out	n/a
EPS (ttm)	28.87
PE Ratio	31.64
Forward PE	n/a
Dividend	5.80 (0.64%)
Ex-Dividend Date	Jul 21, 2025

Volume	768
Average Volume	2,248
Open	936.20
Previous Close	934.00
Day's Range	910.15 - 939.25
52-Week Range	656.25 - 1,197.00
Beta	n/a
RSI	53.45
Earnings Date	Aug 11, 2025

About Windlas Biotech

Windlas Biotech Limited, a contract development and manufacturing organization (CDMO), manufactures and trades in pharmaceutical products in India and internationally. The company offers CDMO solutions, including product development, licensing, and commercial manufacturing of complex drugs and dosage forms. It also produces nutraceutical supplement products. In addition, the company manufactures tablets, capsules, pouches, sachets, and liquid bottles; and generic products portfolio comprising fixed dosage combinations, fixed dosage plus modifie...

• Industry: Pharmaceutical Preparations
• Founded: 2001
• Employees: 1,154
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543329

Financial Performance

In 2024, Windlas Biotech's revenue was 7.60 billion, an increase of 20.43% compared to the previous year's 6.31 billion. Earnings were 609.94 million, an increase of 4.82%.